| |
| |
|
| Insider
Information: |
Ashar Bhavesh |
| Relationship: |
Chief Commercial Officer |
| City: |
Stamford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
56,330 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,330 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Springworks Therapeutics, Inc. |
SWTX |
Chief Commercial Officer |
2024-04-01 |
56,330 |
2021-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2024-04-01 |
4 |
D |
$47.62 |
$86,859 |
D/D |
(1,824) |
56,330 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2024-02-05 |
4 |
AS |
$49.32 |
$238,435 |
D/D |
(4,834) |
58,154 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2024-02-02 |
4 |
AS |
$43.75 |
$142,976 |
D/D |
(3,222) |
62,988 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2024-01-08 |
4 |
D |
$41.53 |
$60,177 |
D/D |
(1,449) |
66,210 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2024-01-05 |
4 |
D |
$37.96 |
$95,166 |
D/D |
(2,507) |
67,659 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
26,445 |
70,166 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2023-04-03 |
4 |
D |
$25.25 |
$34,719 |
D/D |
(1,375) |
43,721 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2023-01-06 |
4 |
D |
$27.52 |
$45,821 |
D/D |
(1,665) |
45,096 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
22,663 |
46,761 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2022-04-01 |
4 |
D |
$56.90 |
$83,302 |
D/D |
(1,464) |
24,098 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2022-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,062 |
25,562 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Chief Commercial Officer |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
